Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 18,960 followers.

RT @FrontOncology: New research: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patient…

28 Sep 2023

Reply Repost Favourite

Frontiers | Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer https://t.co/O1HIaK8uCa

27 Sep 2023

Reply Repost Favourite

New research: Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer: Introduction Small cell lung cancer (SCLC) is a rapidly growing malignancy with… #oncology htt

27 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.